Gevo, Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
GEVO$1.39-5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(In thousands)
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| · · · · Year Ended December 31, | ||||||||
| · Note · · 2024 · 2023 | ||||||||
| Operating Activities · · · | ||||||||
| Net loss | | $(78,640) | | $(66,215) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | | | ||||||
| Stock-based compensation | 14 | | 14,733 | | 17,087 | |||
| Depreciation and amortization | 9, 10 | | 18,298 | | 19,007 | |||
| Amortization of marketable securities discount | | | — | | (102) | |||
| Other noncash expense | | 2,497 | | 908 | ||||
| Changes in operating assets and liabilities, net of effects of acquisition: | | | | | | |||
| Accounts receivable | | 417 | | (2,147) | ||||
| Inventories | 8 | | (706) | | 670 | |||
| Prepaid expenses and other current assets, deposits and other assets | 6, 11 | | (19,050) | | (25,620) | |||
| Accounts payable, accrued expenses and non-current liabilities | 12 | | 5,068 | | 2,693 | |||
| Net cash used in operating activities | | (57,383) | | (53,719) | ||||
| Investing Activities | | | ||||||
| Acquisitions of property, plant and equipment | 9, 22 | | (51,085) | | (54,455) | |||
| Proceeds from sale of investment tax credit | | 1 | | | 15,336 | | | — |
| Payment of earnest money deposit | 11 | | (10,000) | | — | |||
| Acquisition of CultivateAI, net of cash acquired | | 20 | | | (6,070) | | | — |
| Proceeds from maturity of marketable securities | | | — | | 168,550 | |||
| Proceeds from sale of property, plant and equipment | | | | | — | | | 34 |
| Net cash (used in) provided by investing activities | | (51,819) | | 114,129 | ||||
| Financing Activities | | | ||||||
| Proceeds from issuance of Remarketed Bonds | 13 | | 68,155 | | — | |||
| Extinguishment of 2021 Bonds | 13 | | (68,155) | | — | |||
| Payment of debt offering costs | 13 | | (1,665) | | — | |||
| Proceeds from the exercise of warrants | 19 | | 49 | | — | |||
| Payment of loans payable | 13 | | (130) | | (167) | |||
| Payment of finance lease liabilities | 7 | | (906) | | (22) | |||
| Repurchases of common stock | | 19 | | | (4,710) | | | — |
| Net cash used in financing activities | | (7,362) | | (189) | ||||
| Net (decrease) increase in cash and cash equivalents | | (116,564) | | 60,221 | ||||
| Cash, cash equivalents and restricted cash at beginning of period | | 375,597 | | 315,376 | ||||
| Cash, cash equivalents and restricted cash at end of period | | $259,033 | | $375,597 | ||||
(In thousands)
| · · · · · · | ||||
|---|---|---|---|---|
| · · Year Ended December 31, | ||||
| Schedule of cash, cash equivalents and restricted cash · · 2024 · 2023 | ||||
| Cash and cash equivalents | | $189,389 | | $298,349 |
| Restricted cash (current) | | 1,489 | | 77,248 |
| Restricted cash (non-current) | | 68,155 | | — |
| Total cash, cash equivalents and restricted cash | | $259,033 | | $375,597 |
| · · · · · · | ||||
|---|---|---|---|---|
| · · Year Ended December 31, | ||||
| Supplemental disclosures of cash and non-cash investing and financing transactions · · 2024 · 2023 | ||||
| Cash paid for interest | | $1,619 | | $1,029 |
| Non-cash purchase of property, plant and equipment | | $2,595 | | $8,174 |
| Non-cash 401(k) match expense | | $614 | | $— |
| Right-of-use asset purchased with financing leases | | $2,731 | | $— |
| Right-of-use asset purchased with operating lease | | $32 | | $199 |
Notes to Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.